GRADE. Grading of Recommendations Assessment, Development and Evaluation. British Association of Dermatologists April 2018
|
|
- Walter Poole
- 5 years ago
- Views:
Transcription
1 GRADE Grading of Recommendations Assessment, Development and Evaluation British Association of Dermatologists April 2018
2 Previous grading system Level of evidence Strength of recommendation Level of evidence Type of evidence High-quality meta-analyses, systematic reviews of RCTs, or RCTs with a very low risk of bias Well-conducted meta-analyses, systematic reviews of RCTs, or RCTs with a low risk of bias Meta-analyses, systematic reviews of RCTs, or RCTs with a high risk of bias* High-quality systematic reviews of case-control or cohort studies High-quality case-control or cohort studies with a very low risk of confounding, bias or chance and a high probability that the relationship is causal Well-conducted case-control or cohort studies with a low risk of confounding, bias or chance and a moderate probability that the relationship is causal Case-control or cohort studies with a high risk of confounding, bias or chance and a significant risk that the relationship is not causal* 3 Non-analytical studies (for example, case reports, case series) 4 Expert opinion, formal consensus Class A B C D D (GPP) Evidence At least one meta-analysis, systematic review, or RCT rated as 1++, and directly applicable to the target population, or A systematic review of RCTs or a body of evidence consisting principally of studies rated as 1+, directly applicable to the target population and demonstrating overall consistency of results Evidence drawn from a NICE technology appraisal A body of evidence including studies rated as 2++, directly applicable to the target population and demonstrating overall consistency of results, or Extrapolated evidence from studies rated as 1++ or 1+ A body of evidence including studies rated as 2+, directly applicable to the target population and demonstrating overall consistency of results, or Extrapolated evidence from studies rated as 2++ Evidence level 3 or 4, or Extrapolated evidence from studies rated as 2+, or Formal consensus A good practice point (GPP) is a recommendation for best practice based on the experience of the guideline development group *Studies with a level of evidence - should not be used as a basis for making a recommendation. RCT: randomised controlled trial; NICE: National Institute for Health and Care Excellence.
3 Advantages of GRADE over other systems Developed by a widely representative group of international guideline developers and systematic reviewers Clear separation between quality of evidence and strength of recommendations Explicit evaluation of the importance of outcomes of alternative management strategies Explicit & comprehensive criteria for downgrading and upgrading quality of evidence ratings Transparent process of moving from evidence to recommendations (LETR) Explicit acknowledgment of patient values and preferences Clear & pragmatic interpretation of strong vs. weak recommendations for clinicians, patients and policy makers GRADE has been adopted by the WHO, Cochrane Collaboration, NICE, SIGN and around 100 other organisations in 19 countries
4 PICO method a technique used in evidence-based practice to frame and answer a clinical question P: population/patient I: intervention C: comparator/control (if applicable) O: outcome
5 Evidence hierarchy
6 How does GRADE classify the quality of evidence? Evidence: high quality (further research is very unlikely to change our confidence in the estimate of effect) moderate quality (further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate) low quality (further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate) very low quality (any estimate of effect is very uncertain) The quality of evidence reflects the extent to which confidence in an estimate of the effect is adequate to support a particular recommendation
7 How does GRADE classify the quality of evidence? Evidence based on RCTs begins as high quality evidence, but confidence may be decreased due to five factors: 1. study limitations 2. inconsistency of results 3. indirectness of evidence 4. imprecision 5. reporting/publication bias
8 How does GRADE classify the quality of evidence? 1. Domains for study limitations: selection bias lack of allocation concealment or sequence generation performance bias lack of blinding attrition bias loss of participants (dropouts; non-responders; stopping early for benefit; protocol deviators and failure to adhere to an intention-to-treat analysis) measurement/detection bias inaccuracy in the measurement instrument; bias in the expectations of study participants, carers or researchers outcome reporting bias selective outcome-reporting or failure to report outcomes
9 How does GRADE classify the quality of evidence? 2. Inconsistency of results : widely differing estimates of a treatment effect across studies suggest true differences in the underlying treatment effect; i.e. heterogeneity (of pooled results) without plausible explanation 3. Indirectness of evidence: indirect comparisons of the magnitude of effect of drug A vs. drug B when trials = drug A vs. placebo and drug B vs. placebo; indirectness may arise in differences in the P, I, C, O 4. Imprecision: studies with relatively few patients and few events wide CI 5. Reporting/publication bias: failure to report studies or funding issue
10 How does GRADE classify the quality of evidence? For study limitations and indirectness domains, the quality of evidence is assessed: for each study for a particular outcome, then across all studies for that outcome (e.g. in a meta-analysis) For imprecision, inconsistency and publication bias domains, the quality of evidence is assessed for ALL the studies as a whole for a particular outcome (i.e. when appropriate outcome data have been pooled)
11 How does GRADE classify the quality of evidence? Using RCTs as an example, for each outcome, obtain an overall quality rating: 0 if no problems with any of the five factors (high) -1 if problem in one factor (high moderate) -2 if problem in two factors (high low) -3 if problem in three factors (high very low)
12 How does GRADE classify the quality of evidence? Observational studies start with low quality ratings; grading upwards may be warranted if: the magnitude of the treatment effect is large or very large (large effect: RR > 2 or RR < 0.5; very large effect: RR > 5 or RR < 0.2) evidence of a dose-response relationship all plausible confounders/biases would have ordinarily decreased the magnitude of an apparent treatment effect Grading upwards is only possible if evidence has not already been downgraded (e.g. due to study limitations, inconsistency, imprecision) Upgrade to: +1 when RR > 2 or RR < 0.5 = (low moderate) +2 when RR > 5 or RR < 0.2 (low high)
13 How does GRADE classify the quality of evidence? Study design Quality of evidence Lower if Higher if Randomised trials Observational studies High Moderate Low Very low Study limitations Inconsistency Indirectness Imprecision Treatment effect Dose-response relationship Confounders or biases Publication bias
14 Defining outcomes GRADE is outcome-centric Outcome #1 Outcome #2 Outcome #3 Outcome #4 Quality: High Quality: Moderate Quality: Low Quality: Very low Quality: GRADE Previous system Critical outcomes determine the overall quality of evidence
15 Defining outcomes GRADE challenges guideline developers to: specify all outcomes of importance to patients differentiate outcomes that are critical for decision-making from those that are important but not critical, and those that are less important limit to a suggested maximum of 7 outcomes per clinical/review question
16 Defining outcomes Example from BAD guideline on hidradenitis suppurativa (medical interventions): Quality of Life (9) Adverse effects serious (9) Pain (8) Disease-specific physician score (6) Physician s Global Assessment (5) Patient s Global Assessment (5) Adverse effects nuisance (4)
17 Defining outcomes Example from BAD guideline on photodynamic therapy (NMSC): Clearance of treated NMSC at 3 months (9) Sustained clearance at 1, 2 or 5 years (9) Recurrence rate > 1 year (8) Severe pain leading to break in treatment (8) Cosmetic outcome (6) Treatment tolerability low or manageable pain (5) Other adverse effects pigmentation, etc. (4)
18 Decision-making For decision-making need to look at: the outcomes that GDG decides as being critical (i.e. the clinical importance of each outcome): mortality and QoL otherwise, outcomes most likely to affect mortality and QoL the magnitude of effect, as absolute differences/changes and direction, per outcome the overall evidence quality per outcome a GRADE evidence profile can help Judging clinical importance: GDG decides if the effect estimate represents a clinically important difference if there is a clinically important difference, need to indicate the direction (i.e. benefit or harm)
19 How does GRADE classify the strength of recommendations? Factors determining the strength of recommendations: balance between desirable and undesirable effects quality of evidence variability (or uncertainty) in patient values and preferences costs (resource allocation) Desirable effects include: reduction in morbidity & mortality improvement in QoL reduction in the burden of treatment reduction in resource expenditures Undesirable effects include: adverse effects having a deleterious impact on morbidity & mortality, QoL or increase in resource expenditures
20 How does GRADE classify the strength of recommendations? strong (unconditional): desirable effects of an intervention clearly outweigh the undesirable effects (or clearly do not) high-quality methods with large, precise effect low variability or uncertainty in patient values and preferences low resource allocation weak (conditional): desirable effects not clearly greater or smaller than undesirable effects low quality evidence with imprecise estimate patient values and preferences very important high resource allocation N.B. Recommendations to use interventions in a research context may be appropriate
21 Strength of recommendation NICE wording for recommendations: strong: (the benefits clearly outweigh the harms for most people and the intervention is likely to be cost-effective; the guideline panel believes that a vast majority of clinicians and patients would choose a particular intervention if they considered the evidence in the same way that the panel has) OFFER (or similar, e.g. Initiate, Asses, Investigate, etc.) weak: (there is a closer balance between benefits and harm; some patients are averse to some side effects whilst others are not) CONSIDER N.B. Management options associated with strong recommendations are candidates for quality criteria. When recommendations are weak, discussing relative merits of alternative management options with patients and families may become a quality criterion.
22 Grade up Grade down P I C O Outcome Outcome Outcome Outcome Systematic review Critical Critical Important Less Summary of findings & estimate of effect for each outcome High Moderate Low Very low RCT start high, observational data start low 1. Risk of bias 2. Inconsistency 3. Indirectness 4. Imprecision 5. Publication bias 1. Large effect 2. Dose response 3. Confounders Guideline development Formulate recommendations: For or against (direction) Strong or weak (strength) By considering: Quality of evidence Balance benefits/harms Values and preferences Resource use (cost) NICE recommendations: Offer Consider Do not offer GDG reviews the evidence profile for rating the overall quality of evidence
23 ETANERCEPT vs. PLACEBO RevMan meta-analyses and forest plots CRITICAL OUTCOME: Clear/nearly clear (minimal residual activity/pasi>90/pga 0 or 1) at 3-4 months Dose-independent Adults: Strata (children):
24 GRADE evidence profile
25 Next steps GRF and GDG reading background information to aid understanding of the clinical areas developing systematic review protocol(s) designing and testing literature search strategies in a guideline carrying out literature searches based on agreed strategies and key words sifting identified literature based on article titles GDG: working in pairs, sifting shortlisted literature based on abstracts and against inclusion and exclusion criteria set in systematic review protocols reading, data-extracting and critically appraising full texts of shortlisted articles preparing lists of excluded studies (with reasons for exclusion) carrying out data syntheses and meta-analyses using the Review Manager software package preparing summary tables of included systematic reviews, comparative, non-comparative and within-patient studies
26 Next steps GRF and GDG preparing GRADE evidence profiles using the GRADE profiler software package summarising both synthesised and non-synthesised evidence at GDG meetings GDG: attending meeting(s) to discuss the evidence (discussions will be recorded and form part of the LETR) and formulate recommendations GDG: writing introductory/background and other appropriate sections in the main guideline manuscript as required GDG: expanding the discussion points in the LETR into coherent narratives (with reference to evidence identified, synthesised and discussed) in the supplementary information document and finalising the recommendations putting the guideline together (main manuscript and supplementary information, including the PRISMA diagrams) with associated editing and citation work ensuring methodological rigour and compliance with NICE Accreditation criteria documenting all processes and maintaining clear audit trails
GRADE. Grading of Recommendations Assessment, Development and Evaluation. British Association of Dermatologists April 2014
GRADE Grading of Recommendations Assessment, Development and Evaluation British Association of Dermatologists April 2014 Previous grading system Level of evidence Strength of recommendation Level of evidence
More informationCopyright GRADE ING THE QUALITY OF EVIDENCE AND STRENGTH OF RECOMMENDATIONS NANCY SANTESSO, RD, PHD
GRADE ING THE QUALITY OF EVIDENCE AND STRENGTH OF RECOMMENDATIONS NANCY SANTESSO, RD, PHD ASSISTANT PROFESSOR DEPARTMENT OF CLINICAL EPIDEMIOLOGY AND BIOSTATISTICS, MCMASTER UNIVERSITY Nancy Santesso,
More informationACR OA Guideline Development Process Knee and Hip
ACR OA Guideline Development Process Knee and Hip 1. Literature searching frame work Literature searches were developed based on the scenarios. A comprehensive search strategy was used to guide the process
More informationIntroduzione al metodo GRADE
Introduzione al metodo GRADE Atto Billio MD, MSc EBHC Ematologia e TMO-Bolzano Gruppo linee guida SIE Critique of EBM De-emphasizes patient values Doesn t account for individual variation Devalues clinical
More informationObjectives. Information proliferation. Guidelines: Evidence or Expert opinion or???? 21/01/2017. Evidence-based clinical decisions
Guidelines: Evidence or Expert opinion or???? Objectives Need for guidelines? Prakesh Shah Professor, Department of Pediatrics, Mount Sinai Hospital Institute of Health Policy Management and Evaluation
More informationWhy is ILCOR moving to GRADE?
1 Why is ILCOR moving to GRADE? Associate Professor Peter Morley Director Medical Education Royal Melbourne Hospital University of Melbourne 10 min 2 3 4 5 6 7 Apart from international consensus Allows
More informationResults. NeuRA Hypnosis June 2016
Introduction may be experienced as an altered state of consciousness or as a state of relaxation. There is no agreed framework for administering hypnosis, but the procedure often involves induction (such
More informationGRADE, Summary of Findings and ConQual Workshop
GRADE, Summary of Findings and ConQual Workshop To discuss Introduction New JBI Levels of Evidence and Grades of Recommendation Moving towards GRADE Summary of Findings tables Qualitative Levels Conclusion
More informationWashington, DC, November 9, 2009 Institute of Medicine
Holger Schünemann, MD, PhD Chair, Department of Clinical Epidemiology & Biostatistics Michael Gent Chair in Healthcare Research McMaster University, Hamilton, Canada Washington, DC, November 9, 2009 Institute
More informationAlcohol interventions in secondary and further education
National Institute for Health and Care Excellence Guideline version (Draft for Consultation) Alcohol interventions in secondary and further education NICE guideline: methods NICE guideline Methods
More informationSystematic reviews and meta-analyses of observational studies (MOOSE): Checklist.
Systematic reviews and meta-analyses of observational studies (MOOSE): Checklist. MOOSE Checklist Infliximab reduces hospitalizations and surgery interventions in patients with inflammatory bowel disease:
More informationTraumatic brain injury
Introduction It is well established that traumatic brain injury increases the risk for a wide range of neuropsychiatric disturbances, however there is little consensus on whether it is a risk factor for
More informationProblem solving therapy
Introduction People with severe mental illnesses such as schizophrenia may show impairments in problem-solving ability. Remediation interventions such as problem solving skills training can help people
More informationGLOSSARY OF GENERAL TERMS
GLOSSARY OF GENERAL TERMS Absolute risk reduction Absolute risk reduction (ARR) is the difference between the event rate in the control group (CER) and the event rate in the treated group (EER). ARR =
More informationResults. NeuRA Mindfulness and acceptance therapies August 2018
Introduction involve intentional and non-judgmental focus of one's attention on emotions, thoughts and sensations that are occurring in the present moment. The aim is to open awareness to present experiences,
More informationDeterminants of quality: Factors that lower or increase the quality of evidence
Determinants of quality: Factors that lower or increase the quality of evidence GRADE Workshop CBO, NHG and Dutch Cochrane Centre CBO, April 17th, 2013 Outline The GRADE approach: step by step Factors
More informationNeuRA Sleep disturbance April 2016
Introduction People with schizophrenia may show disturbances in the amount, or the quality of sleep they generally receive. Typically sleep follows a characteristic pattern of four stages, where stage
More informationDistraction techniques
Introduction are a form of coping skills enhancement, taught during cognitive behavioural therapy. These techniques are used to distract and draw attention away from the auditory symptoms of schizophrenia,
More informationResults. NeuRA Worldwide incidence April 2016
Introduction The incidence of schizophrenia refers to how many new cases there are per population in a specified time period. It is different from prevalence, which refers to how many existing cases there
More informationAnimal-assisted therapy
Introduction Animal-assisted interventions use trained animals to help improve physical, mental and social functions in people with schizophrenia. It is a goal-directed intervention in which an animal
More informationResults. NeuRA Treatments for internalised stigma December 2017
Introduction Internalised stigma occurs within an individual, such that a person s attitude may reinforce a negative self-perception of mental disorders, resulting in reduced sense of selfworth, anticipation
More informationEvaluating the Strength of Clinical Recommendations in the Medical Literature: GRADE, SORT, and AGREE
Evaluating the Strength of Clinical Recommendations in the Medical Literature: GRADE, SORT, and AGREE Mayra Buainain de Castro Maymone 1, Stephanie D. Gan 2 and Michael Bigby 3 Journal of Investigative
More informationResults. NeuRA Forensic settings April 2016
Introduction Prevalence quantifies the proportion of individuals in a population who have a disease during a specific time period. Many studies have reported a high prevalence of various health problems,
More informationMeta Analysis. David R Urbach MD MSc Outcomes Research Course December 4, 2014
Meta Analysis David R Urbach MD MSc Outcomes Research Course December 4, 2014 Overview Definitions Identifying studies Appraising studies Quantitative synthesis Presentation of results Examining heterogeneity
More informationEvidence Based Medicine
Course Goals Goals 1. Understand basic concepts of evidence based medicine (EBM) and how EBM facilitates optimal patient care. 2. Develop a basic understanding of how clinical research studies are designed
More informationResults. NeuRA Treatments for dual diagnosis August 2016
Introduction Many treatments have been targeted to improving symptom severity for people suffering schizophrenia in combination with substance use problems. Studies of dual diagnosis often investigate
More informationAttention deficit hyperactivity disorder: diagnosis and management (update)
National Institute for Health and Care Excellence Final Attention deficit hyperactivity disorder: diagnosis and management (update) NICE guideline: methods NICE guideline NG87 March 2018 Final Developed
More informationCritical Appraisal Series
Definition for therapeutic study Terms Definitions Study design section Observational descriptive studies Observational analytical studies Experimental studies Pragmatic trial Cluster trial Researcher
More informationTranscranial Direct-Current Stimulation
Introduction (tdcs) is a non-invasive form of brain stimulation similar to transcranial magnetic stimulation, but instead of using magnets, it uses a lowintensity, constant current applied through scalp
More informationCritical appraisal: Systematic Review & Meta-analysis
Critical appraisal: Systematic Review & Meta-analysis Atiporn Ingsathit MD.PhD. Section for Clinical Epidemiology and biostatistics Faculty of Medicine Ramathibodi Hospital Mahidol University What is a
More informationResults. NeuRA Motor dysfunction April 2016
Introduction Subtle deviations in various developmental trajectories during childhood and adolescence may foreshadow the later development of schizophrenia. Studies exploring these deviations (antecedents)
More informationTypes of Data. Systematic Reviews: Data Synthesis Professor Jodie Dodd 4/12/2014. Acknowledgements: Emily Bain Australasian Cochrane Centre
Early Nutrition Workshop, December 2014 Systematic Reviews: Data Synthesis Professor Jodie Dodd 1 Types of Data Acknowledgements: Emily Bain Australasian Cochrane Centre 2 1 What are dichotomous outcomes?
More informationResults. NeuRA Herbal medicines August 2016
Introduction have been suggested as a potential alternative treatment which may positively contribute to the treatment of schizophrenia. Herbal therapies can include traditional Chinese medicines and Indian
More informationMethod. NeuRA Biofeedback May 2016
Introduction is a technique in which information about the person s body is fed back to the person so that they may be trained to alter the body s conditions. Physical therapists use biofeedback to help
More informationSystematic Reviews. Simon Gates 8 March 2007
Systematic Reviews Simon Gates 8 March 2007 Contents Reviewing of research Why we need reviews Traditional narrative reviews Systematic reviews Components of systematic reviews Conclusions Key reference
More informationOverview and Comparisons of Risk of Bias and Strength of Evidence Assessment Tools: Opportunities and Challenges of Application in Developing DRIs
Workshop on Guiding Principles for the Inclusion of Chronic Diseases Endpoints in Future Dietary Reference Intakes (DRIs) Overview and Comparisons of Risk of Bias and Strength of Evidence Assessment Tools:
More informationResults. NeuRA Family relationships May 2017
Introduction Familial expressed emotion involving hostility, emotional over-involvement, and critical comments has been associated with increased psychotic relapse in people with schizophrenia, so these
More informationNeuRA Obsessive-compulsive disorders October 2017
Introduction (OCDs) involve persistent and intrusive thoughts (obsessions) and repetitive actions (compulsions). The DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition) defines
More informationEvidence-based practice tutorial Critical Appraisal Skills
Evidence-based practice tutorial Critical Appraisal Skills Earlier evidence based practice tutorials have focussed on skills to search various useful sites on the internet for evidence. Anyone who has
More informationQuality of Clinical Practice Guidelines
Evidence Based Dentistry Quality of Clinical Practice Guidelines Asbjørn Jokstad University of Oslo, Norway 07/04/2005 1 Justification for developing guidelines Demand for effectiveness and efficacy studies
More informationPost-traumatic stress disorder
National Institute for Health and Care Excellence Final Post-traumatic stress disorder Methods NICE guideline NG116 Supplement 1 December 2018 Final These evidence reviews were developed by the National
More informationModule 5. The Epidemiological Basis of Randomised Controlled Trials. Landon Myer School of Public Health & Family Medicine, University of Cape Town
Module 5 The Epidemiological Basis of Randomised Controlled Trials Landon Myer School of Public Health & Family Medicine, University of Cape Town Introduction The Randomised Controlled Trial (RCT) is the
More informationCochrane Pregnancy and Childbirth Group Methodological Guidelines
Cochrane Pregnancy and Childbirth Group Methodological Guidelines [Prepared by Simon Gates: July 2009, updated July 2012] These guidelines are intended to aid quality and consistency across the reviews
More informationMethod. NeuRA Paliperidone August 2016
Introduction Second generation antipsychotics (sometimes referred to as atypical antipsychotics) are a newer class of antipsychotic medication than first generation typical antipsychotics. Second generation
More informationCEU screening programme: Overview of common errors & good practice in Cochrane intervention reviews
CEU screening programme: Overview of common errors & good practice in Cochrane intervention reviews Since September 2013, the CEU has been responsible for pre-publication screening of new intervention
More informationPractice guidelines : overview of methodology with focus on GRADE
Practice guidelines : overview of methodology with focus on GRADE Benjamin Djulbegovic, M.D.,Ph.D. Distinguished Professor USF, Dpt of Internal Medicine Chief, Division of Evidence-based Medicine and Health
More informationControlled Trials. Spyros Kitsiou, PhD
Assessing Risk of Bias in Randomized Controlled Trials Spyros Kitsiou, PhD Assistant Professor Department of Biomedical and Health Information Sciences College of Applied Health Sciences University of
More informationStandards for the reporting of new Cochrane Intervention Reviews
Methodological Expectations of Cochrane Intervention Reviews (MECIR) Standards for the reporting of new Cochrane Intervention Reviews 24 September 2012 Preface The standards below summarize proposed attributes
More informationPROSPERO International prospective register of systematic reviews
PROSPERO International prospective register of systematic reviews Closed reduction methods for acute anterior shoulder dislocation [Cochrane Protocol] Kanthan Theivendran, Raj Thakrar, Subodh Deshmukh,
More informationNeuRA Decision making April 2016
Introduction requires an individual to use their knowledge and experience of a context in order to choose a course of action 1. A person s ability to autonomously make decisions is referred to as their
More informationSOF: Summary of Findings tables. Negrar, 7 aprile 2018
SOF: Summary of Findings tables Negrar, 7 aprile 2018 Grade up Grade down 2 3 Randomization raises initial quality RCTs: high Observational: low P I C O Outcome Outcome Outcome Outcome Evidence synthesis
More informationRecent developments for combining evidence within evidence streams: bias-adjusted meta-analysis
EFSA/EBTC Colloquium, 25 October 2017 Recent developments for combining evidence within evidence streams: bias-adjusted meta-analysis Julian Higgins University of Bristol 1 Introduction to concepts Standard
More informationIntroduction to systematic reviews/metaanalysis
Introduction to systematic reviews/metaanalysis Hania Szajewska The Medical University of Warsaw Department of Paediatrics hania@ipgate.pl Do I needknowledgeon systematicreviews? Bastian H, Glasziou P,
More informationMeta-analyses: analyses:
Meta-analyses: analyses: how do they help, and when can they not? Lee Hooper Senior Lecturer in research synthesis & nutrition l.hooper@uea.ac.uk 01603 591268 Aims Systematic Reviews Discuss the scientific
More informationSUPPLEMENTARY DATA. Supplementary Figure S1. Search terms*
Supplementary Figure S1. Search terms* *mh = exploded MeSH: Medical subject heading (Medline medical index term); tw = text word; pt = publication type; the asterisk (*) stands for any character(s) #1:
More informationSystematic Review & Course outline. Lecture (20%) Class discussion & tutorial (30%)
Systematic Review & Meta-analysisanalysis Ammarin Thakkinstian, Ph.D. Section for Clinical Epidemiology and Biostatistics Faculty of Medicine, Ramathibodi Hospital Tel: 02-201-1269, 02-201-1762 Fax: 02-2011284
More informationResults. NeuRA Essential fatty acids August 2016
Introduction Alternative treatments are investigated as a possible replacement for antipsychotic medication, which can be associated with severe side effects. Alternative therapies may have less debilitating
More informationMINI SYMPOSIUM - EUMASS - UEMASS European Union of Medicine in Assurance and Social Security
MINI SYMPOSIUM - EUMASS - UEMASS European Union of Medicine in Assurance and Social Security Quality of Evidence and Grades of Recommendations in guidelines A role for insurance medicine? Prof. Regina
More informationReporting the effects of an intervention in EPOC reviews. Version: 21 June 2018 Cochrane Effective Practice and Organisation of Care Group
Reporting the effects of an intervention in EPOC reviews Version: 21 June 2018 Cochrane Effective Practice and Organisation of Care Group Feedback on how to improve this resource is welcome and should
More informationLIHS Mini Master Class
Alexandru Nicusor Matei 2013 CC BY-NC-ND 2.0 Grading the evidence Liz Mitchell Liz Mitchell University of Leeds 2015. This work is made available for reuse under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike
More informationMeta-Analysis. Zifei Liu. Biological and Agricultural Engineering
Meta-Analysis Zifei Liu What is a meta-analysis; why perform a metaanalysis? How a meta-analysis work some basic concepts and principles Steps of Meta-analysis Cautions on meta-analysis 2 What is Meta-analysis
More informationClinical Epidemiology for the uninitiated
Clinical epidemiologist have one foot in clinical care and the other in clinical practice research. As clinical epidemiologists we apply a wide array of scientific principles, strategies and tactics to
More informationEssential Skills for Evidence-based Practice Understanding and Using Systematic Reviews
J Nurs Sci Vol.28 No.4 Oct - Dec 2010 Essential Skills for Evidence-based Practice Understanding and Using Systematic Reviews Jeanne Grace Corresponding author: J Grace E-mail: Jeanne_Grace@urmc.rochester.edu
More informationEvidence Based Medicine
Hamadan University of medical sciences School of Public Health Department of Epidemiology Evidence Based Medicine Amin Doosti-Irani, PhD in Epidemiology 10 March 2017 a_doostiirani@yahoo.com 1 Outlines
More informationGrading the Evidence Developing the Typhoid Statement. Manitoba 10 th Annual Travel Conference April 26, 2012
Grading the Evidence Developing the Typhoid Statement Manitoba 10 th Annual Travel Conference April 26, 2012 Disclosure of Potential Conflict of Interest Alexandra Henteleff MEd, BN, RN Certificate in
More informationCONSORT 2010 checklist of information to include when reporting a randomised trial*
CONSORT 2010 checklist of information to include when reporting a randomised trial* Section/Topic Title and abstract Introduction Background and objectives Item No Checklist item 1a Identification as a
More informationEvidence based practice. Dr. Rehab Gwada
Evidence based practice Dr. Rehab Gwada Objectives Define the ABP Identify the steps of the EBP process Recognize hierarchy of evidence and types of study design Explain how to build focused clinical questions
More informationSystematic reviews: From evidence to recommendation. Marcel Dijkers, PhD, FACRM Icahn School of Medicine at Mount Sinai
Systematic reviews: From evidence to recommendation Session 2 - June 18, 2014 Going beyond design, going beyond intervention: The American Academy of Neurology (AAN) Clinical Practice Guideline process
More informationMeta-Analyses: Considerations for Probiotics & Prebiotics Studies
Meta-Analyses: Considerations for Probiotics & Prebiotics Studies Daniel J. Tancredi, PhD Associate Professor in Residence Department of Pediatrics UC Davis School of Medicine Objectives Provide an overview
More informationSYSTEMATIC REVIEW: AN APPROACH FOR TRANSPARENT RESEARCH SYNTHESIS
SYSTEMATIC REVIEW: AN APPROACH FOR TRANSPARENT RESEARCH SYNTHESIS A Case Study By Anil Khedkar, India (Masters in Pharmaceutical Science, PhD in Clinical Research Student of Texila American University)
More information1. Draft checklist for judging on quality of animal studies (Van der Worp et al., 2010)
Appendix C Quality appraisal tools (QATs) 1. Draft checklist for judging on quality of animal studies (Van der Worp et al., 2010) 2. NICE Checklist for qualitative studies (2012) 3. The Critical Appraisal
More informationPROSPERO International prospective register of systematic reviews
PROSPERO International prospective register of systematic reviews High-dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents and young adults with first
More informationSystematic Reviews and Meta- Analysis in Kidney Transplantation
Systematic Reviews and Meta- Analysis in Kidney Transplantation Greg Knoll MD MSc Associate Professor of Medicine Medical Director, Kidney Transplantation University of Ottawa and The Ottawa Hospital KRESCENT
More informationComponent of CPG development ILAE Recommendation Document Identifying topic and developing clinical. S3 research question
S1: Summary of recommendations for developing Clinical Practice Guidelines Minimum CPG development requirements (where resources are more limited) are bolded. When full resources are available, every recommendation
More informationSchool of Dentistry. What is a systematic review?
School of Dentistry What is a systematic review? Screen Shot 2012-12-12 at 09.38.42 Where do I find the best evidence? The Literature Information overload 2 million articles published a year 20,000 biomedical
More informationThe comparison or control group may be allocated a placebo intervention, an alternative real intervention or no intervention at all.
1. RANDOMISED CONTROLLED TRIALS (Treatment studies) (Relevant JAMA User s Guides, Numbers IIA & B: references (3,4) Introduction: The most valid study design for assessing the effectiveness (both the benefits
More informationA Cochrane systematic review of interventions to improve hearing aid use
A Cochrane systematic review of interventions to improve hearing aid use Fiona Barker f.barker@surrey.ac.uk Department of Healthcare Management and Policy The context Hearing loss is a common long term
More informationGATE CAT Intervention RCT/Cohort Studies
GATE: a Graphic Approach To Evidence based practice updates from previous version in red Critically Appraised Topic (CAT): Applying the 5 steps of Evidence Based Practice Using evidence about interventions
More informationGATE: Graphic Appraisal Tool for Epidemiology picture, 2 formulas & 3 acronyms
GATE: Graphic Appraisal Tool for Epidemiology 1991-2015 1 picture, 2 formulas & 3 acronyms 1 GATE: Graphic Appraisal Tool for Epidemiology Graphic Architectural Tool for Epidemiology Graphic Approach To
More informationDoes the evidence directly answer my question?
Does the evidence directly answer my question? " " " "! Domain!(original!question! asked)! Population:!All!patients! with!advanced!cancer! Intervention:!Heparins!! Comparator:!No! anticoagulation! Direct!comparison!
More informationOverview of Study Designs in Clinical Research
Overview of Study Designs in Clinical Research Systematic Reviews (SR), Meta-Analysis Best Evidence / Evidence Guidelines + Evidence Summaries Randomized, controlled trials (RCT) Clinical trials, Cohort
More informationCochrane-GRADE Workshop
Cochrane-GRADE Workshop Modena, June 2017 Holger Schünemann, Elena Parmelli, Sara Balduzzi Jane Noyes, Heather Munthe-Kaas, Claire Glenton Background / history of GRADE and GRADE CERQual Deep vein thrombosis
More informationOutcomes and GRADE Summary of Findings Tables: old and new
Holger Schünemann, MD, PhD Chair, Dept. of Clinical Epidemiology & Biostatistics Professor of Clinical Epidemiology & Biostatistics and of Medicine Michael Gent Chair in Healthcare Research McMaster University,
More informationStandard Methods for Quality Assessment of Evidence
Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35, Salem, Oregon 97301 1079 Phone 503 947 5220 Fax 503 947 1119 Standard Methods for Quality Assessment of Evidence
More informationGRADE tables to assist guideline development and recommendations. Plain Language Summary of Results
Seasonal Malaria Chemoprevention (formally known as Intermittent Preventive Treatment in children) for preventing malaria morbidity in children aged less than 5 years living in areas of marked seasonal
More informationGuideline development in TB diagnostics. Karen R Steingart, MD, MPH McGill University, Montreal, July 2011
Guideline development in TB diagnostics Karen R Steingart, MD, MPH McGill University, Montreal, July 2011 karenst@uw.edu Overview What are guidelines? Quality of guidelines The Grade approach IOM standards
More informationMapping from SORT to GRADE. Brian S. Alper, MD, MSPH, FAAFP Editor-in-Chief, DynaMed October 31, 2013
Mapping from SORT to GRADE Brian S. Alper, MD, MSPH, FAAFP Editor-in-Chief, DynaMed October 31, 2013 Disclosures Brian S. Alper MD, MSPH, FAAFP is editor-in-chief for DynaMed (published by EBSCO) and medical
More informationEvidence Based Practice
Evidence Based Practice RCS 6740 7/26/04 Evidence Based Practice: Definitions Evidence based practice is the integration of the best available external clinical evidence from systematic research with individual
More informationImplementing scientific evidence into clinical practice guidelines
Evidence Based Dentistry Implementing scientific evidence into clinical practice guidelines Asbjørn Jokstad University of Oslo, Norway 15/07/2004 1 PRACTICE GUIDELINES IN DENTISTRY (Medline) 2100 1945
More informationGlossary of Practical Epidemiology Concepts
Glossary of Practical Epidemiology Concepts - 2009 Adapted from the McMaster EBCP Workshop 2003, McMaster University, Hamilton, Ont. Note that open access to the much of the materials used in the Epi-546
More informationAuthors face many challenges when summarising results in reviews.
Describing results Authors face many challenges when summarising results in reviews. This document aims to help authors to develop clear, consistent messages about the effects of interventions in reviews,
More informationRheumatoid arthritis in adults: diagnosis and management
National Institute for Health and Care Excellence Final Rheumatoid arthritis in adults: diagnosis and management Rheumatoid arthritis: methods NICE guideline NG100 July 2018 Final Developed by the National
More informationAppendix A: Literature search strategy
Appendix A: Literature search strategy The following databases were searched: Cochrane Library Medline Embase CINAHL World Health organisation library Index Medicus for the Eastern Mediterranean Region(IMEMR),
More informationRevman Plots: Glucose child up to 2 yrs Distress Acute
Revman Plots: Glucose child up to 2 yrs Distress Acute without data from study by Goswami 2013 (2) due to co interventions (holding) Distress Acute + Recovery without data from study by Morelius 2009 (4)
More informationNeuRA Schizophrenia diagnosis May 2017
Introduction Diagnostic scales are widely used within clinical practice and research settings to ensure consistency of illness ratings. These scales have been extensively validated and provide a set of
More informationDATE: 22 May 2013 CONTEXT AND POLICY ISSUES
TITLE: Intraperitoneal versus Intravenous Chemotherapy for the Treatment of Ovarian Cancer: A Review of the Comparative Clinical Evidence, Safety, Cost- Effectiveness, and Guidelines DATE: 22 May 2013
More informationCHECK-LISTS AND Tools DR F. R E Z A E I DR E. G H A D E R I K U R D I S TA N U N I V E R S I T Y O F M E D I C A L S C I E N C E S
CHECK-LISTS AND Tools DR F. R E Z A E I DR E. G H A D E R I K U R D I S TA N U N I V E R S I T Y O F M E D I C A L S C I E N C E S What is critical appraisal? Critical appraisal is the assessment of evidence
More informationA Systematic Review of the Efficacy and Clinical Effectiveness of Group Analysis and Analytic/Dynamic Group Psychotherapy
A Systematic Review of the Efficacy and Clinical Effectiveness of Group Analysis and Analytic/Dynamic Group Psychotherapy Executive summary Aims of the review The main aim of the review was to assess the
More informationGuideline Development at the American College of Physicians. American College of Physicians
Guideline Development at the American College of Physicians Melissa Starkey, PhD American College of Physicians Institute of Medicine Committee on Preventive Services for Women March 9, 2011 Who is ACP?
More informationMethod. NeuRA Cholinesterase inhibitors August 2016
Introduction A supplementary, or adjunctive, treatment is administered in conjunction with a patient s ongoing antipsychotic therapy. (ChEI), or anticholinesterase, have been proposed as an additional
More information